Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 673

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Effect of Intra-arrest Transport, Extracorporeal Cardiopulmonary Resuscitation, and Immediate Invasive Assessment and Treatment on Functional Neurologic Outcome in Refractory Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial

Open access
Belohlavek, Jan, Smalcova, Jana, Rob, Daniel, Franek, Ondrej, Smid, Ondrej, Pokorna, Milana, Horák, Jan, Mrazek, Vratislav, Kovarnik, Tomas, Zemanek, David, Kral, Ales, Havranek, Stepan, Kavalkova, Petra, Kompelentova, Lucie, Tomková, Helena, Mejstrik, Alan, Valasek, Jaroslav, Peran, David, Pekara, Jaroslav, Rulisek, Jan, Balik, Martin, Huptych, Michal, Jarkovsky, Jiri, Malik, Jan, Valerianova, Anna, Mlejnsky, Frantisek, Kolouch, Petr, Havrankova, Petra, Romportl, Dan, Komarek, Arnost, Linhart, Ales, Prague OHCA Study Group, Aschermann, Michael, Jeřábek, Štěpán, Paďour, Michal, Šimek, Jan, Otáhal, Michal, Flaksa, Marek, Lálová, Ilona, Hubatová, Markéta, Pořízka, Michal, Skalická, Hana·2022·JAMA

Abstract

Importance: Out-of-hospital cardiac arrest (OHCA) has poor outcome. Whether intra-arrest transport, extracorporeal cardiopulmonary resuscitation (ECPR), and immediate invasive assessment and treatment (invasive strategy) is beneficial in this setting remains uncertain. Objective: To determine whether an early invasive approach in adults with refractory OHCA improves neurologically favorable survival. Design, Setting, and Participants: Single-center, randomized clinical trial in Prague, Czech Republic, of adults with a witnessed OHCA of presumed cardiac origin without return of spontaneous circulation. A total of 256 participants, of a planned sample size of 285, were enrolled between March 2013 and October 2020. Patients were observed until death or day 180 (last patient follow-up ended on March 30, 2021). Interventions: In the invasive strategy group (n = 124), mechanical compression was initiated, followed by intra-arrest transport to a cardiac center for ECPR and immediate invasive assessment and treatment. Regular advanced cardiac life support was continued on-site in the standard strategy group (n = 132). Main Outcomes and Measures: The primary outcome was survival with a good neurologic outcome (defined as Cerebral Performance Category [CPC] 1-2) at 180 days after randomization. Secondary outcomes included neurologic recovery at 30 days (defined as CPC 1-2 at any time within the first 30 days) and cardiac recovery at 30 days (defined as no need for pharmacological or mechanical cardiac support for at least 24 hours). Results: The trial was stopped at the recommendation of the data and safety monitoring board when prespecified criteria for futility were met. Among 256 patients (median age, 58 years; 44 [17%] women), 256 (100%) completed the trial. In the main analysis, 39 patients (31.5%) in the invasive strategy group and 29 (22.0%) in the standard strategy group survived to 180 days with good neurologic outcome (odds ratio [OR], 1.63 [95% CI, 0.93 to 2.85]; difference, 9.5% [95% CI, -1.3% to 20.1%]; P = .09). At 30 days, neurologic recovery had occurred in 38 patients (30.6%) in the invasive strategy group and in 24 (18.2%) in the standard strategy group (OR, 1.99 [95% CI, 1.11 to 3.57]; difference, 12.4% [95% CI, 1.9% to 22.7%]; P = .02), and cardiac recovery had occurred in 54 (43.5%) and 45 (34.1%) patients, respectively (OR, 1.49 [95% CI, 0.91 to 2.47]; difference, 9.4% [95% CI, -2.5% to 21%]; P = .12). Bleeding occurred more frequently in the invasive strategy vs standard strategy group (31% vs 15%, respectively). Conclusions and Relevance: Among patients with refractory out-of-hospital cardiac arrest, the bundle of early intra-arrest transport, ECPR, and invasive assessment and treatment did not significantly improve survival with neurologically favorable outcome at 180 days compared with standard resuscitation. However, the trial was possibly underpowered to detect a clinically relevant difference. Trial Registration: ClinicalTrials.gov Identifier: NCT01511666.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jama.2022.1025

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 33 references

Cited by

See all 673

Metadata

Authors
Belohlavek, J., Smalcova, J., Rob, D., Franek, O., Smid, O., Pokorna, M., Horák, J., Mrazek, V., Kovarnik, T., Zemanek, D., Kral, A., Havranek, S., Kavalkova, P., Kompelentova, L., Tomková, H., Mejstrik, A., Valasek, J., Peran, D., Pekara, J., Rulisek, J., Balik, M., Huptych, M., Jarkovsky, J., Malik, J., Valerianova, A., Mlejnsky, F., Kolouch, P., Havrankova, P., Romportl, D., Komarek, A., Linhart, A., Prague OHCA Study Group, Aschermann, M., Jeřábek, Š., Paďour, M., Šimek, J., Otáhal, M., Flaksa, M., Lálová, I., Hubatová, M., Pořízka, M., & Skalická, H.
Venue
JAMA
Published
2022-02-22
Volume
327
Issue
8
Pages
737
ISSN
  • 0002-9955 (ISSN-L)
  • 0098-7484
OpenAlex
W4213294877
Cited by
673
References
33
FWCI
149.85
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of Intra-arrest Transport, Extracorporeal Cardiopulmonary Resuscitation, and Immediate Invasive Assessment and Treatment on Functional Neurologic Outcome in Refractory Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial. https://app.cochat.ai/papers/10.1001/jama.2022.1025
The paper
Belohlavek, J., Smalcova, J., Rob, D., Franek, O., Smid, O., Pokorna, M., Horák, J., Mrazek, V., Kovarnik, T., Zemanek, D., Kral, A., Havranek, S., Kavalkova, P., Kompelentova, L., Tomková, H., Mejstrik, A., Valasek, J., Peran, D., Pekara, J., . . . Skalická, H. (2022). Effect of Intra-arrest Transport, Extracorporeal Cardiopulmonary Resuscitation, and Immediate Invasive Assessment and Treatment on Functional Neurologic Outcome in Refractory Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial. JAMA. https://doi.org/10.1001/jama.2022.1025

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.